Prochlorperazine dimaleate (also known as Prochlorperazin, Compazine, Capazine, Stemetil), the dimaleate salt of Prochlorperazine, is a dopamine (D2) receptor antagonist that belongs to the phenothiazine class of antipsychotic agents that are used for the antiemetic treatment of nausea and vertigo.
Fluoroclebopride is useful chemical for PET image study. [18F]fluoroclebopride had been used for PET imaging of dopamine D2 receptors in monkeys.
Fenoldopam (SKF-82526) is a synthetic benzazepine analog acting as a selective D1 receptor partial agonist.
Rotigotine (formerly N-0437; N-0923; N0437; N0923; trade names Neupro among others) is a potent, non-selective full agonist of dopamine receptor that has been approved for use in the treatment of PD/Parkinson’s disease and restless legs syndrome.
Benztropine mesylate (NSC-42199; ST-50997629; NSC 42199; ST 50997629; Cogentin; MLS000737056), the mesilate salt of Benztropine, is a highly potent dopamine transporter (DAT) inhibitor used for the treatment of symptoms of Parkinson’s disease such as involuntary tremor and dystonia.
Eticlopride HCl (FLB131; FLB-131) is a potent antipsychotic agent acting as a selective dopamine D2‐like receptor antagonist.
Rotigotine Hydrochloride (N-0437; N-0923) is a potent, non-selective and dopamine receptor full agonist, used in the treatment of Parkinson’s disease and restless legs syndrome.
Lurasidone HCl (SM-13496; SM 13496; trade name Latuda), the hydrochloride salt of Lurasidone, is an atypical antipsychotic drug that has been approved for the treatment of schizophrenia and bipolar disorder.
rac-Rotigotine Hydrochloride is the racemic mixture of Rotigotine (N-0437; N-0923), which is a potent, non-selective and dopamine receptor full agonist, used in the treatment of Parkinson’s disease and restless legs syndrome.
Spiperone HCl (NSC-170983; E-525; R-5147; Spiroperidol) is a novel and potent antipsychotic agent acting as a dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2A antagonist with the potential for neurology diseases.